NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

metrics 2024

Transforming Understanding through Neurobiological Advances

Introduction

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY is a premier journal dedicated to advancing the understanding of the intricate relationships between pathology and neurobiology. Published by Wiley since 1975, this journal has established itself as a crucial resource for researchers, clinicians, and students interested in the latest insights and developments in the fields of pathology, neurology, and neuroscience. With an impressive history of convergence extending to 2024, it boasts a Q1 ranking in multiple categories including Histology, Neurology, and Pathology, reflecting its high impact and reputation in the academic community. Additionally, it ranks 18th out of 208 in Pathology and Forensic Medicine with a remarkable 91st percentile, signifying its relevance and influence in medical research. While not open access, this journal provides valuable content that contributes significantly to the ongoing discourse in neurobiological advancements and is a vital reference for those engaged in this dynamic field.

Metrics 2024

SCIMAGO Journal Rank1.59
Journal Impact Factor4.00
Journal Impact Factor (5 years)5.10
H-Index108
Journal IF Without Self4.00
Eigen Factor0.00
Normal Eigen Factor0.92
Influence1.65
Immediacy Index0.70
Cited Half Life9.00
Citing Half Life8.70
JCI1.19
Total Documents1642
WOS Total Citations4431
SCIMAGO Total Citations17695
SCIMAGO SELF Citations437
Scopus Journal Rank1.59
Cites / Document (2 Years)3.92
Cites / Document (3 Years)4.13
Cites / Document (4 Years)4.11

Metrics History

Rank 2024

Scopus

Pathology and Forensic Medicine in Medicine
Rank #18/208
Percentile 91.35
Quartile Q1
Histology in Medicine
Rank #9/62
Percentile 85.48
Quartile Q1
Neurology (clinical) in Medicine
Rank #63/400
Percentile 84.25
Quartile Q1
Neurology in Neuroscience
Rank #34/192
Percentile 82.29
Quartile Q1
Physiology (medical) in Medicine
Rank #24/113
Percentile 78.76
Quartile Q1

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 51/277
Percentile 81.80
Quartile Q1
NEUROSCIENCES
Rank 86/310
Percentile 72.40
Quartile Q2
PATHOLOGY
Rank 15/88
Percentile 83.50
Quartile Q1

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 54/278
Percentile 80.58
Quartile Q1
NEUROSCIENCES
Rank 70/310
Percentile 77.42
Quartile Q1
PATHOLOGY
Rank 15/88
Percentile 82.95
Quartile Q1

Quartile History

Similar Journals

JOURNAL OF PATHOLOGY

Exploring the Depths of Disease Mechanisms
Publisher: WILEYISSN: 0022-3417Frequency: 12 issues/year

Welcome to the Journal of Pathology, a premier academic publication specializing in the field of pathology and forensic medicine. Established in 1969 and published by Wiley, this journal has garnered significant recognition within the research community, reflected in its impressive ranking of #6 out of 208 in Scopus, placing it in the 97th percentile. The Journal of Pathology serves as a critical platform for disseminating cutting-edge research findings, innovative methodologies, and topical reviews that advance our understanding of diseases and their underlying mechanisms. With no open access charge, this esteemed journal is committed to maintaining the highest standards of scientific rigor and integrity. As a Q1 journal in its category for 2023, it continues to shape the field of pathology and contribute invaluable insights to researchers, medical professionals, and students alike. We invite you to explore the wealth of knowledge encapsulated in each issue and engage with the vibrant discussions that strive to propel the science of pathology forward.

Molecular Neurodegeneration

Empowering research in molecular neuroscience.
Publisher: BMCISSN: Frequency: 1 issue/year

Molecular Neurodegeneration is a leading journal published by BMC, dedicated to advancing the field of neurodegeneration through high-quality, open-access research. Since its inception in 2006, this peer-reviewed journal has provided a pivotal platform for the dissemination of innovative findings in the realms of Cellular and Molecular Neuroscience, Molecular Biology, and Clinical Neurology. With a stellar impact factor and listed in the prestigious Q1 category in multiple relevant categories, it ranks among the top publications in the field—specifically, it holds the #3 position in Neuroscience and #6 position in Clinical Neurology based on Scopus metrics. Researchers, professionals, and students alike will find significant value in the open access format, which fosters unrestricted sharing of knowledge, ensuring that emerging ideas in neurodegeneration reach a global audience. Based in London, United Kingdom, the journal promises a comprehensive scope that addresses critical questions in neurobiology, making it an essential resource for anyone interested in the molecular mechanisms underlying neurodegenerative diseases.

ENDOCRINE PATHOLOGY

Delivering Impactful Research for Better Patient Outcomes
Publisher: HUMANA PRESS INCISSN: 1046-3976Frequency: 4 issues/year

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.

JOURNAL OF CUTANEOUS PATHOLOGY

Elevating Knowledge in Histology and Dermatopathology
Publisher: WILEYISSN: 0303-6987Frequency: 10 issues/year

JOURNAL OF CUTANEOUS PATHOLOGY, published by WILEY, serves as a vital resource in the fields of dermatology, pathology, and histology, reflecting its distinguished position with impressive categorization quartiles: Q2 in Dermatology and Pathology and Forensic Medicine, and Q3 in Histology for 2023. Established in 1974, this esteemed journal features peer-reviewed research that drives advancements in understanding skin diseases, with a convergence period extending to 2024. The journal's impactful contributions are evident through its Scopus rankings, placing it among the top tiers of its category, specifically holding the 52nd rank in Dermatology. Researchers, professionals, and students will find the journal invaluable for its rich content and critical insights into cutaneous pathology, despite its current non-open access status. The journal's dedication to fostering knowledge in this specialized field underlines its significance as a go-to reference for ongoing scholarship and clinical practice.

NEUROSCIENCE

Fostering excellence in neuroscience scholarship.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0306-4522Frequency: 24 issues/year

NEUROSCIENCE, published by PERGAMON-ELSEVIER SCIENCE LTD, has established itself as a reputable journal in the field of neuroscience since its inception in 1976, continuing its contributions through 2024. With a Category Quartile ranking of Q2 in Neuroscience (miscellaneous) and a Scopus Rank of #41 out of 113, this journal represents a critical platform for the dissemination of innovative research and insights. Although it currently does not offer open access options, NEUROSCIENCE aims to advance our understanding of the nervous system by publishing high-quality original research, reviews, and methodological articles, thereby engaging a comprehensive audience of researchers, professionals, and students alike. With an impact factor that reflects its significance in the scientific community, this journal remains a go-to source for cutting-edge discoveries and scholarly discussions in the dynamic field of neuroscience.

Neurology-Neuroimmunology & Neuroinflammation

Fostering collaboration in the fight against neuroinflammatory disorders.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2332-7812Frequency: 6 issues/year

Neurology-Neuroimmunology & Neuroinflammation, published by LIPPINCOTT WILLIAMS & WILKINS, stands at the forefront of research in the rapidly evolving fields of neurology and neuroimmunology. Since its inception in 2014, this prestigious journal has embraced an Open Access model, ensuring that groundbreaking findings are readily available to researchers, clinicians, and students worldwide. Covering a broad spectrum of topics related to neuroinflammation, the journal has gained a remarkable reputation, attaining a Q1 ranking in both Neurology and Neurology (clinical) as of 2023, and ranking #6 out of 192 in the neuroscience category on Scopus. The journal's commitment to high-quality research aims to facilitate the understanding of neurological disorders, promote innovative therapies, and inspire collaboration among professionals. Addressing critical issues at the intersection of neurology, immunology, and clinical practice, Neurology-Neuroimmunology & Neuroinflammation is an essential platform for the dissemination of knowledge and the advancement of this vital field.

EXPERIMENTAL NEUROLOGY

Transforming Insights into Neurological Understanding.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0014-4886Frequency: 12 issues/year

EXPERIMENTAL NEUROLOGY is a premier academic journal published by Academic Press Inc, Elsevier Science, focusing on advancements in the fields of Developmental Neuroscience and Neurology. With an impressive Impact Factor and ranked in the Q1 quartile of both categories—positioning it among the top-tier journals—this publication has established itself as a vital resource for researchers, clinicians, and students alike. Since its inception in 1959, it has fostered the dissemination of cutting-edge research and innovative approaches to understanding neurological function and related disorders. While EXPERIMENTAL NEUROLOGY currently operates under a subscription access model, its rich archives and ongoing contributions to the field continue to inspire and inform the next generation of neurobiologists. The journal also boasts a high ranking in Scopus, placing fourth in Developmental Neuroscience and twentieth in Neurology, indicating its robust influence and scholarly significance. For those committed to advancing knowledge in these critical areas, EXPERIMENTAL NEUROLOGY is an indispensable platform for inquiry and discovery.

INTERNATIONAL JOURNAL OF NEUROSCIENCE

Championing Breakthroughs in Neuroscience Research
Publisher: TAYLOR & FRANCIS LTDISSN: 0020-7454Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF NEUROSCIENCE, published by TAYLOR & FRANCIS LTD, stands as a vital resource in the field of neuroscience since its inception. With a proud history of publication from 1970 to 2024, this journal is committed to advancing knowledge in various domains of neuroscience, from fundamental research to clinical applications. It is indexed with an ISSN of 0020-7454 and an E-ISSN of 1563-5279, reflecting its wide reach and recognition. The journal maintains a respectable position in the academic landscape, categorized as Q2 in Medicine (miscellaneous) and Q3 in Neuroscience (miscellaneous) as of 2023, signifying its relevance among researchers and professionals. Although it currently does not offer open access, the journal remains a significant platform for disseminating groundbreaking research, thereby fostering collaboration and innovation within the neuroscience community. Located in the United Kingdom, the journal aims to bridge gaps in neuroscience knowledge, making it an essential reading for students, professionals, and researchers dedicated to unraveling the complexities of the nervous system.

Acta Neuropathologica Communications

Exploring the Depths of Neuroscience Research.
Publisher: BMCISSN: 2051-5960Frequency: 1 issue/year

Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.

ANNALS OF NEUROLOGY

Pioneering Research in Neurology and Clinical Practices
Publisher: WILEYISSN: 0364-5134Frequency: 12 issues/year

ANNALS OF NEUROLOGY, published by Wiley, stands as a leading journal in the field of neurology, renowned for its rigorous peer-reviewed articles that contribute significantly to the understanding of neurological disorders and advances in clinical practices. With an impressive impact factor and ranked Q1 in both neurology and clinical neurology categories, this journal positions itself among the top repositories of cutting-edge research, indexed in Scopus with exemplary ranks in the 98th and 97th percentiles respectively. Since its inception in 1977 and with a commitment to excellence extending to 2024 and beyond, ANNALS OF NEUROLOGY aims to disseminate groundbreaking studies and foster dialogue within the academic community, making it an essential resource for researchers, healthcare professionals, and students dedicated to neurology. Although it does not currently offer open access, its accessibility through institutional subscriptions facilitates widespread scholarly engagement.